A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan clinical oncology group study JCOG0508

Japanese Journal of Clinical Oncology

Volumn 39, Issue 10, 2009, Pages 686-689

  Kurokawa, Yukinori ^a,b   Muto, Manabu ^c   Minashi, Keiko ^d   Boku, Narikazu ^e   Fukuda, Haruhiko ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Chemoradiotherapy; Endoscopic mucosal resection; Superficial esophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGUS CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; MULTICENTER STUDY; OVERALL SURVIVAL; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SURVIVAL TIME; CARCINOMA; ESOPHAGUS TUMOR; FEMALE; GASTROINTESTINAL ENDOSCOPY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL; STOMACH MUCOSA; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA; CLINICAL TRIALS, PHASE I AS TOPIC; COMBINED MODALITY THERAPY; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; FEMALE; GASTRIC MUCOSA; HUMANS; JAPAN; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349935461     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp078     Document Type: Article

References (8)

1. Japanese Classification of Esophageal Cancer. 10th edition. Tokyo: Japan Esophageal Society, Kanehara, Co., Ltd. 2008.
2. Kato H, Tachimori Y, Mizobuchi S, Igaki H, Ochiai A. Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial esophageal carcinoma of the thoracic esophagus. Cancer 1993;72:2879-82.
3. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998;123:432-9.
4. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
5. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999;17:2915-21.
6. Kato H, Udagawa H, Togo A, Ando N, Tanaka O, Shinoda M, et al. A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group study (JCOG9708). Proc Am Soc Clin Oncol 2003;22:aBstr 1147.
7. Minashi K, Ohtsu A, Mera K, Muto M, Yano T, Tahara M, et al. Combination of endoscopic mucosal resection and chemoradiotherapy as a nonsurgical treatments for patients with clinical stage I esophageal squamous cell carcinoma. J Clin Oncol 2007;25(Suppl 18):4529.
8. Makuuchi H. Esophageal endoscopic mucosal resection (EEMR) tube. Surg Laparosc Endosc 1996;6:160-1.